I would wait until it has passed its moving averages, it is under every one of them..the 20 and 50 are coming together, if it breaks above with volume you might have a trade..if it fails then a retest is in the cards..
Mr. Stephen Chang, Chairman of Progen, commented: "The Board remains committed and excited at the future prospects of Progen and the accelerated development of our anti-cancer drug candidate PI-88 for the treatment of post-resection liver cancer and this sentiment is evidenced by our participation in this capital raising activity."
Mr. Linton Burns, Progen's CFO, added: "With the closing of this entitlements offer the Company now is in a very strong financial position with approximately $A100M in cash reserves. We now have sufficient funding to conduct the Phase 3 development of PI-88, complete the other necessary trials for registration and scale-up and validate the PI-88 manufacturing process."
About Progen: Progen Pharmaceuticals Limited is an Australian-based globally focused biotechnology company committed to the discovery, development and commercialisation of small molecule therapeutics primarily for the treatment of cancer.
Mr. Stephen Chang, Chairman of Progen, commented: "The Board remains committed and excited at the future prospects of Progen and the accelerated development of our anti-cancer drug candidate PI-88 for the treatment of post-resection liver cancer and this sentiment is evidenced by our participation in this capital raising activity."
Mr. Linton Burns, Progen's CFO, added: "With the closing of this entitlements offer the Company now is in a very strong financial position with approximately $A100M in cash reserves. We now have sufficient funding to conduct the Phase 3 development of PI-88, complete the other necessary trials for registration and scale-up and validate the PI-88 manufacturing process."
About Progen: Progen Pharmaceuticals Limited is an Australian-based globally focused biotechnology company committed to the discovery, development and commercialisation of small molecule therapeutics primarily for the treatment of cancer.
If you choose to make use of any information on this website including online sports betting services from any websites that may be featured on this website, we strongly recommend that you carefully check your local laws before doing so.It is your sole responsibility to understand your local laws and observe them strictly.Covers does not provide any advice or guidance as to the legality of online sports betting or other online gambling activities within your jurisdiction and you are responsible for complying with laws that are applicable to you in your relevant locality.Covers disclaims all liability associated with your use of this website and use of any information contained on it.As a condition of using this website, you agree to hold the owner of this website harmless from any claims arising from your use of any services on any third party website that may be featured by Covers.